Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Poor water-solubility limits the total use of the drug in the human body of many recently discovered drugs. Recently, Amorphous Solid Dispersion (ASD) technique is being used as an efficient way to enhance solubility of poorly soluble drugs which are prevalent in pharmaceutical industry while providing sustained release, however the instability of ASD may cause recrystallization of the drug, decreasing the utility and may cause side effects. Controlled release (CR) coating with a novel terpolymeric nanoparticle (TPN) as pore forming material is proven to be an effective way to reduce the side effects, and the recrystallization inhibition effect of the TPN as pore former should be studied, benefiting the partner organization with new insights to controlled release formulations.
Xiao Yu Shirley Wu
Candoo Pharmatech Company Inc.
Life Sciences
Professional, scientific and technical services
University of Toronto
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.